Publications and Research
Document Type
Article
Publication Date
6-1-2017
Abstract
In this study, label-free fluorescence spectroscopy was used for the first time to determine spectral profiles of tryptophan, reduced nicotinamide adenine dinucleotide (NADH), and flavin denine dinucleotide (FAD) in fresh brain samples of a mouse model of Alzheimer’s disease (AD). Our results showed that the emission spectral profile levels of tryptophan and NADH were higher in AD samples than normal samples. The intensity ratio of tryptophan to NADH and the change rate of fluorescence intensity with respect to wavelength also increased in AD brain. These results yield an optical method for detecting early stage of AD by comparing spectral profiles of biomolecules.
Comments
This article was originally published in Scientific Reports, available at DOI:10.1038/s41598-017-02673-5.
This article is licensed under a Creative Commons Attribution 4.0 International License.